Exact Mass: 411.10420020000004

Exact Mass Matches: 411.10420020000004

Found 160 metabolites which its exact mass value is equals to given mass value 411.10420020000004, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Mandipropamid

Pesticide4_Mandipropamid_C23H22ClNO4_2-(4-Chlorophenyl)-N-{2-[3-methoxy-4-(2-propyn-1-yloxy)phenyl]ethyl}-2-(2-propyn-1-yloxy)acetamide

C23H22ClNO4 (411.1237282000001)

D016573 - Agrochemicals D010575 - Pesticides CONFIDENCE standard compound; EAWAG_UCHEM_ID 3061

Altanserin

3-{2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl}-2-sulfanylidene-1,2,3,4-tetrahydroquinazolin-4-one

C22H22FN3O2S (411.1416684)

D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist Altanserin can synthesize Fluorine-18 Altanserin. Fluorine-18 Altanserin binds to the brain 5HT2 receptors[1].

Gonyautoxin I

{4-[(carbamoyloxy)methyl]-5,10,10-trihydroxy-2,6-diimino-decahydropyrrolo[1,2-c]purin-9-yl}oxidanesulfonic acid

C10H17N7O9S (411.0808432)

Gonyautoxin I is found in mollusks. Gonyautoxin I is produced by Gonyaulax and Protogonyaulax species and isolated from shellfish. Neurotoxin, causal agent, with Saxitoxin, of shellfish poisoning. From Gonyaulax and Protogonyaulax subspecies Gonyautoxin IV is found in mollusks. D009676 - Noxae > D011042 - Poisons > D008978 - Mollusk Venoms D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins D009676 - Noxae > D011042 - Poisons > D014688 - Venoms

Tiagabine hydrochloride

C20H26ClNO2S2 (411.10934060000005)

D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D058805 - GABA Uptake Inhibitors C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants D018377 - Neurotransmitter Agents > D018682 - GABA Agents D049990 - Membrane Transport Modulators Tiagabine hydrochloride is a potent and selective GABA reuptake inhibitor, used as an anticonvulsant agent, with IC50s of 67, 446 and 182 nM for [3H]GABA uptake in Synaptosomes, Neurons and Glia, respectively[1].

Ipratropium bromide

C20H30BrNO3 (411.140893)

R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BB - Anticholinergics R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents Ipratropium bromide (Sch 1000) is a muscarinic receptor antagonist, with IC50s of 2.9 nM, 2 nM, and 1.7 nM for M1, M2, and M3 receptors, respectively. Ipratropium bromide relaxes smooth muscle, can be used in the research for COPD (chronic obstructive pulmonary disease) and asthma[1][2][3][4][5].

N6-carbamoylthreonyladenosine

(2S,3R)-N-{9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-9H-purin-6-yl}-3-hydroxy-2-[(C-hydroxycarbonimidoyl)amino]butanimidate

C15H21N7O7 (411.1502396)

N6-Carbamoyl-L-threonyladenosine is a member of the class of compounds known as purine nucleosides. Purine nucleosides are compounds composed of a purine base attached to a ribosyl or deoxyribosyl moiety. N6-Carbamoyl-L-threonyladenosine is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Within the cell, N6-carbamoyl-L-threonyladenosine is primarily located in the cytoplasm. It can also be found in the extracellular space. N6-Carbamoyl-L-threonyladenosine is a minor constituent found in human and bovine milk (PMID: 7702711). Minor constituant found in human, bovine, and goat milk

Sulfociprofloxacin

1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(4-sulfO-1-piperazinyl)-3-quinolinecarboxylic acid

C17H18FN3O6S (411.09003000000007)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones

Cetocycline

3-acetyl-1-amino-4,4a,6,7-tetrahydroxy-8,11-dimethyl-1,2,4a,5,12,12a-hexahydrotetracene-2,5-dione

C22H21NO7 (411.13179560000003)

N-(2(S)-(Acetylthiomethyl)-3-(2-methylphenyl)-1-oxopropyl)-L-methionine ethyl ester

3-(Acetylsulphanyl)-N-[1-ethoxy-4-(methylsulphanyl)-1-oxobutan-2-yl]-2-[(2-methylphenyl)methyl]propanimidic acid

C20H29NO4S2 (411.15379140000005)

Sulfo-ciprofloxacin

1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-2-sulphO-1,4-dihydroquinoline-3-carboxylic acid

C17H18FN3O6S (411.09003000000007)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones

N-(4-((5-(3-(2-Aminoethyl)-1H-indol-5-yl)-1,2,4-oxadiazol-3-yl)methyl)phenyl)methanesulfonamide

N-[4-({5-[3-(2-aminoethyl)-1H-indol-5-yl]-1,2,4-oxadiazol-3-yl}methyl)phenyl]methanesulphonamide

C20H21N5O3S (411.1365036000001)

Acetamide, N-(((5S)-3-(3-fluoro-4-(6-(1-methyl-1H-tetrazol-5-yl)-3-pyridinyl)phenyl)-2-oxo-5-oxazolidinyl)methyl)-

N-[(3-{3-fluoro-4-[6-(1-methyl-1H-1,2,3,4-tetrazol-5-yl)pyridin-3-yl]phenyl}-2-oxo-1,3-oxazolidin-5-yl)methyl]ethanimidate

C19H18FN7O3 (411.14550900000006)

1-O-(3-Hydroxybutyryl)pancratistatin

C18H21NO10 (411.1165406)

4-[3-(trifluoromethyl)phenyl]-5-(3,4,5-trimethoxyphenyl)-4H-1,2,4-triazole-3-thiol

C18H16F3N3O3S (411.0864422000001)

4-[[4-(4-fluorophenyl)-3-piperidinyl]methoxy]-2-methoxy-, hydrogen sulfate (ester), (3S-trans)-Pheno

C19H22FNO6S (411.11518040000004)

Met Met Met

C15H29N3O4S3 (411.1320114)

Sulfociprofloxacin

C17H18FN3O6S (411.09003000000007)

An organosulfonic acid that is ciprofloxacin carrying a sulfo group at position 4 of the piperazine ring. It is a metabolite of ciprofloxacin. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones

Asp Phe Met

C18H25N3O6S1 (411.14639900000003)

Phe Asp Met

C18H25N3O6S1 (411.14639900000003)

Met Phe Asp

C18H25N3O6S1 (411.14639900000003)

Met Asp Phe

C18H25N3O6S1 (411.14639900000003)

Asp Met Phe

C18H25N3O6S1 (411.14639900000003)

Galβ1-4Glcβ-Sp

C14H25N3O11 (411.148902)

Val-Trp-OH

(S)-3-(1H-indol-3-yl)-2-(3-isopropoxy-4-nitrobenzamido)propanoic acid

C21H21N3O6 (411.14302860000004)

Trp-Abu-OH

(S)-2-(3-(2-(1H-indol-3-yl)ethoxy)-4-nitrobenzamido)pentanoic acid

C21H21N3O6 (411.14302860000004)

Gonyautoxin IV

C10H17N7O9S (411.0808432)

(4-(N-Benzyl-N-(4-methoxybenzyl)sulfamoyl)phenyl)boronic acid

C21H22BNO5S (411.13116720000005)

Resorufin β-D-glucuronide sodium salt

C18H14NNaO9 (411.05662340000003)

N-(4-acetylphenyl)-4-hydroxy-N-[(4-methoxyphenyl)methyl]benzenesulfonamide

C22H21NO5S (411.1140376000001)

4-(4-TERT-BUTYLPHENYL)-N-(2-CHLOROPHENYL)-5-CYAN-AMIDE-4,5-DIHYDRO-1,3,4-THIADIAZOLE-2-CARBOXAMIDE

C20H18ClN5OS (411.09205280000003)

Cadrofloxacin

C19H20F3N3O4 (411.14058360000007)

2,3,5-TRI-O-ACETYL-8-FLUORO ADENOSINE

C16H18FN5O7 (411.11902100000003)

2.4.6-TRICHLORO-1.3.5-TRIPHENYLBORAZINE

C18H15B3Cl3N3 (411.06106500000004)

Oxitropium Bromide

C19H26BrNO4 (411.10450960000003)

4-Aminodibenzo-18-crown-6 hydrochloride

C20H26ClNO6 (411.1448566000001)

(2s,4s)-1-t-butoxycarbonyl-2-(N-T-butoxycarbonyl-N-sulfamoylamino)methyl-4-mercapto-pyrrolidine

C15H29N3O6S2 (411.1497694)

ZM 323881 HCl

ZM 323881 hydrochloride

C22H19ClFN3O2 (411.11497560000004)

O-benzyl-L-methionine toluene-p-sulphonate

C19H25NO5S2 (411.117408)

4(1H)-Pyridazinone, 6-methyl-3-(2-quinolinylmethoxy)-1-(3-(trifluorome thyl)phenyl)-

C22H16F3N3O2 (411.1194552)

Fmoc-gly-gly-gly-oh

C21H21N3O6 (411.14302860000004)

Thiazolidine, 2-(4-methylphenyl)-3-[(4-phenoxyphenyl)sulfonyl]- (9CI)

C22H21NO3S2 (411.09627960000006)

2,3,5-Tri-O-acetyl-2-fluoroadenosine

C16H18FN5O7 (411.11902100000003)

L-694247

N-(4-((5-(3-(2-Aminoethyl)-1H-indol-5-yl)-1,2,4-oxadiazol-3-yl)methyl)phenyl)methanesulfonamide

C20H21N5O3S (411.1365036000001)

Trimethionine

H-Met-Met-Met-OH

C15H29N3O4S3 (411.1320114)

9-Mesityl-10-methylacridinium perchlorate

C23H22ClNO4 (411.1237282000001)

Sofosbuvir metabolites GS566500

C13H19FN3O9P (411.08429060000003)

3-(1,1-Dioxido-4h-1,2,4-Benzothiadiazin-3-Yl)-4-Hydroxy-1-(3-Methylbutyl)quinolin-2(1h)-One

C21H21N3O4S (411.1252706000001)

Bendamustine hydrochloride monohydrate

C16H24Cl3N3O3 (411.08831640000005)

Pizotifen maleate

C23H25NO4S (411.15042100000005)

Allyl-{4-[3-(4-bromo-phenyl)-benzofuran-6-yloxy]-but-2-enyl}-methyl-amine

C22H22BrNO2 (411.0833812)

5-(6-d-Ribitylamino-2,4-dihydroxypyrimidin-5-yl)-1-pentyl-phosphonic acid

C14H26N3O9P (411.1406596)

4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile

C18H16F3N3O5 (411.10420020000004)

S-{3-[(4-Anilinoquinazolin-6-YL)amino]-3-oxopropyl}-L-cysteine

C20H21N5O3S (411.1365036000001)

Methyl 3-Chloro-2-{3-[(2,5-Dihydroxy-4-Methoxyphenyl)amino]-3-Oxopropyl}-4,6-Dihydroxybenzoate

C18H18ClNO8 (411.0720898)

4-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one

C17H19F6N3O2 (411.1381386)

N-(2(S)-(Acetylthiomethyl)-3-(2-methylphenyl)-1-oxopropyl)-L-methionine ethyl ester

3-(Acetylsulphanyl)-N-[1-ethoxy-4-(methylsulphanyl)-1-oxobutan-2-yl]-2-[(2-methylphenyl)methyl]propanimidic acid

C20H29NO4S2 (411.15379140000005)

4-hydroxy-rot-2-enonate

C23H23O7- (411.1443708)

5-Hydroxy-rot-2-enonate

C23H23O7- (411.1443708)

N-[[3-[3-fluoro-4-[6-(1-methyltetrazol-5-yl)pyridin-3-yl]phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide

C19H18FN7O3 (411.14550900000006)

(6-chloro-2,3,4,9-tetrahydro-1H-carbazol-1-yl)-[4-[2-furanyl(oxo)methyl]-1-piperazinyl]methanone

C22H22ClN3O3 (411.1349612)

Gonyautoxin-1

C10H17N7O9S (411.0808432)

(S)-mandipropamid

C23H22ClNO4 (411.1237282000001)

2-methyl-3-{4-[4-(trifluoromethoxy)phenoxy]phenyl}quinolin-4(1H)-one

C23H16F3NO3 (411.1082222)

Dichotomide XII, (rel)-

C21H21N3O6 (411.14302860000004)

A natural product found in Stellaria dichotoma var. lanceolata.

N-[3-(4-methyl-1-piperazinyl)-1,4-dioxo-2-naphthalenyl]benzenesulfonamide

C21H21N3O4S (411.1252706000001)

1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[3-fluoro-4-(1H-pyrazolo[3,4-d]pyrimidin-4-yloxy)phenyl]urea

C19H18FN7O3 (411.14550900000006)

4-[3-[4-[2-Furanyl(oxo)methyl]-1-piperazinyl]-2,5-dioxo-1-pyrrolidinyl]benzoic acid methyl ester

C21H21N3O6 (411.14302860000004)

3-[6,6-dimethyl-3-(methylthio)-4-oxo-5,7-dihydro-2-benzothiophen-1-yl]-N-phenyl-1-pyrazolecarboxamide

C21H21N3O2S2 (411.1075126)

4-chloro-3-(diethylsulfamoyl)-N-(2-nitrophenyl)benzamide

C17H18ClN3O5S (411.06556480000006)

5-cyclopropyl-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-7-(trifluoromethyl)-1,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-2-carboxamide

C18H20F3N5OS (411.13405860000006)

N-[2-(2,3-dimethylphenyl)-5,5-dioxo-4,6-dihydrothieno[3,4-c]pyrazol-3-yl]-2-methoxybenzamide

C21H21N3O4S (411.1252706000001)

N-(1,3-benzothiazol-2-yl)-2-(3-methoxyphenyl)-4-quinolinecarboxamide

C24H17N3O2S (411.1041422)

2-(3-oxo-4H-1,4-benzothiazin-2-yl)acetic acid (7-methoxy-2-oxo-1-benzopyran-4-yl)methyl ester

C21H17NO6S (411.07765420000004)

1-(3,5-Dimethyl-1-piperidinyl)-2-[[2-(thiophen-2-ylmethyl)-4-quinazolinyl]thio]ethanone

C22H25N3OS2 (411.143896)

2-(3-ethylphenoxy)-N-[4-(2-pyridinylsulfamoyl)phenyl]acetamide

C21H21N3O4S (411.1252706000001)

N-(1,3-benzothiazol-2-yl)-2-[[5-(4-methoxyphenyl)-4-methyl-1,2,4-triazol-3-yl]thio]acetamide

C19H17N5O2S2 (411.0823622)

2-(4-Ethoxy-3-methoxyphenyl)-3-(4-methoxyphenyl)-6-oxo-4-sulfanyl-1,2-dihydropyrimidine-5-carbonitrile

C21H21N3O4S (411.1252706000001)

4-[[7-Methyl-4-(phenylthio)-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-2-yl]methyl]morpholine

C22H25N3OS2 (411.143896)

2-[(5,6-Dimethyl-2-propyl-4-thieno[2,3-d]pyrimidinyl)thio]-1-(2-methyl-2,3-dihydroindol-1-yl)ethanone

C22H25N3OS2 (411.143896)

2-(5-chloropyridin-2-yl)-4-[(E)-(5-ethyl-1,3,4-thiadiazol-2-yl)iminomethyl]-3-hydroxyisoquinolin-1-one

C19H14ClN5O2S (411.05566940000006)

(E)-2-(1H-benzimidazol-2-yl)-N-(furan-2-ylmethyl)-3-[3-(trifluoromethyl)phenyl]prop-2-enamide

C22H16F3N3O2 (411.1194552)

N-{[(1S,2R)-1-carboxylato-2-hydroxypropyl]carbamoyl}adenosine

C15H19N6O8- (411.1264314)

QSY35 succinimidyl ester

C18H13N5O7 (411.08149480000003)

Dnp-Nor-Gln

C16H21N5O8 (411.1390066)

Asp-Tyr-Asp

C17H21N3O9 (411.12777360000007)

Met-Asp-Phe

C18H25N3O6S (411.14639900000003)

Tyr-Asp-Asp

C17H21N3O9 (411.12777360000007)

(R)-mandipropamid

C23H22ClNO4 (411.1237282000001)

2-(4-bromophenyl)-1-(4-ethoxyphenyl)-6,7,8,9-tetrahydro-5H-imidazo[1,2-a]azepin-4-ium

C22H24BrN2O+ (411.1071894)

5-Carboxymethylaminomethyluridine 5-monophosphate

C12H18N3O11P (411.06789280000004)

(2S,3S,4S)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-1-(pyridine-3-carbonyl)azetidine-2-carbonitrile

C25H18FN3O2 (411.13829799999996)

(2R,3S,4S)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-1-(pyridine-3-carbonyl)azetidine-2-carbonitrile

C25H18FN3O2 (411.13829799999996)

(2R,3S,4R)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-1-[oxo(3-pyridinyl)methyl]-2-azetidinecarbonitrile

C25H18FN3O2 (411.13829799999996)

(2S,3R,4S)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-1-[oxo(3-pyridinyl)methyl]-2-azetidinecarbonitrile

C25H18FN3O2 (411.13829799999996)

(2S,3R,4R)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-1-[oxo(3-pyridinyl)methyl]-2-azetidinecarbonitrile

C25H18FN3O2 (411.13829799999996)

(2R,3R,4R)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-1-[oxo(3-pyridinyl)methyl]-2-azetidinecarbonitrile

C25H18FN3O2 (411.13829799999996)

(1R,2aS,8bS)-N-(4-chlorophenyl)-2-[cyclopropyl(oxo)methyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

C22H22ClN3O3 (411.1349612)

(1S,2aR,8bR)-N-(4-chlorophenyl)-2-[cyclopropyl(oxo)methyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

C22H22ClN3O3 (411.1349612)

(2S,3S,4R)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-1-[oxo(3-pyridinyl)methyl]-2-azetidinecarbonitrile

C25H18FN3O2 (411.13829799999996)

(1S,2aS,8bS)-N-(4-chlorophenyl)-2-[cyclopropyl(oxo)methyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

C22H22ClN3O3 (411.1349612)

(1R,2aR,8bR)-N-(4-chlorophenyl)-2-[cyclopropyl(oxo)methyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

C22H22ClN3O3 (411.1349612)

Asp-Asp-Tyr

C17H21N3O9 (411.12777360000007)

Asp-Phe-Met

C18H25N3O6S (411.14639900000003)

Met-Phe-Asp

C18H25N3O6S (411.14639900000003)

Asp-Met-Phe

C18H25N3O6S (411.14639900000003)

Phe-Asp-Met

C18H25N3O6S (411.14639900000003)

Phe-Met-Asp

C18H25N3O6S (411.14639900000003)

(2-amino-5,10,10-trihydroxy-6-imino-9-sulfooxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl)methyl carbamate

C10H17N7O9S (411.0808432)

Gonyautoxin I

C10H17N7O9S (411.0808432)

N-[(9-beta-D-ribofuranosylpurin-6-yl)carbamoyl]threonate

C15H19N6O8 (411.1264314)

A hydroxy monocarboxylic acid anion that is the conjugate base of N-[(9-beta-D-ribofuranosylpurin-6-yl)carbamoyl]threonine, obtained by deprotonation of the carboxy group; major species at pH 7.3.

Gonyautoxin 1

C10H17N7O9S (411.0808432)

LPC 7:3;O3

C15H26NO10P (411.12942660000004)

LPS 8:3;O2

C14H22NO11P (411.0930432)

Met-Met-Met

C15H29N3O4S3 (411.1320114)

E-3620

C20H27Cl2N3O2 (411.1480222)

E-3620 is a potent 5-HT3 receptor antagonist. E-3620 can be used for the research of dyskinesi and gastrointestinal motility[1][2].

VU6019650

C18H22FN3O3S2 (411.10865540000003)

VU6019650 is a potent and selective orthosteric antagonist of M5 mAChR (IC50=36 nM), can be used for opioid use disorder (OUD) relief. VU6019650 can cross blood brain barrier, potentially modulates the mesolimbic dopaminergic reward circuitry. VU6019650 blocks Oxotremorine M iodide (HY-101372A) induced increases of neuronal firing rates of midbrain dopamine neurons in the ventral tegmental area (VTA)[1][2].

2-(1-{1-acetyl-9h-pyrido[3,4-b]indol-3-yl}-n-methylformamido)-5-methoxy-5-oxopentanoic acid

C21H21N3O6 (411.14302860000004)

3,4-dihydroxyphenethyl

C19H23BrClNO2 (411.06005880000004)

{"Ingredient_id": "HBIN007409","Ingredient_name": "3,4-dihydroxyphenethyl","Alias": "NA","Ingredient_formula": "C19H23BrClNO2","Ingredient_Smile": "C1CN(CCC1C2=CC=C(C=C2)Cl)CCC3=CC(=C(C=C3)O)O.Br","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "32830","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(1r,4ar,12as)-3-acetyl-1-amino-4,4a,6,7-tetrahydroxy-8,11-dimethyl-12,12a-dihydro-1h-tetracene-2,5-dione

C22H21NO7 (411.13179560000003)

[5,10,10-trihydroxy-2,6-diimino-9-(sulfooxy)-hexahydropyrrolo[1,2-c]purin-4-yl]methoxycarboximidic acid

C10H17N7O9S (411.0808432)

(2s,3r,4s,5r,6s)-6-(4-{[(2-ethoxy-2-sulfanylideneethylidene)amino]methyl}phenoxy)-4,5-dihydroxy-2-methyloxan-3-yl acetate

C19H25NO7S (411.135166)

(3as,4r,9r,10as)-6-amino-10,10-dihydroxy-4-[(c-hydroxycarbonimidoyloxy)methyl]-2-imino-9-(sulfooxy)-1h,3h,3ah,4h,8h,9h-pyrrolo[1,2-c]purin-5-ium-5-olate

C10H17N7O9S (411.0808432)

(5r,8s,9r)-8-benzoyl-2-(5-ethylfuran-2-yl)-6,9-dihydroxy-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

C22H21NO7 (411.13179560000003)

(1r,2r,3s,4s,4ar,11br)-2,3,4,6,7-pentahydroxy-1h,2h,3h,4h,4ah,9h,11bh-[1,3]dioxolo[4,5-j]phenanthridin-1-yl (3s)-3-hydroxybutanoate

C18H21NO10 (411.1165406)